HPR93 Analysis of Real-World Evidence Role in US FDA Approvals of Novel Drugs and Post Marketing Requirements of RWE Study (Novel Drug Approvals US FDA 2023)
Abstract
Authors
S Sachdeva J Kaneria RS Shah
S Sachdeva J Kaneria RS Shah
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now